Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
165 results:

  • 1. Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery.
    Procházka V; Lacina L; Smetana K; Svoboda M; Skřivanová K; Beňovská M; Jarkovský J; Křen L; Kala Z
    World J Surg Oncol; 2023 Dec; 21(1):384. PubMed ID: 38098074
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk factors for reoperation within 30 days in laparoscopic colorectal cancer surgery: A Japanese multicenter study.
    Oishi K; Tominaga T; Ono R; Noda K; Hashimoto S; Shiraishi T; Takamura Y; Nonaka T; Ishii M; Fukuoka H; Hisanaga M; Takeshita H; To K; Tanaka K; Sawai T; Nagayasu T
    Asian J Endosc Surg; 2024 Jan; 17(1):e13257. PubMed ID: 37944946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival Outcome in Early-Onset Metastatic colorectal cancer: A Multicenter-Matched Pair Analysis.
    Doleschal B; Niedersüß-Beke D; Kirchweger P; Petzer A; Thaler J; Rumpold H
    Oncology; 2024; 102(2):107-113. PubMed ID: 37699362
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. treatment and Survival Among Patients With colorectal cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study.
    Hämmerl L; Mezger NCS; Seraphin TP; Joko-Fru WY; Griesel M; Feuchtner J; Gnahatin F; Gnangnon FHR; Okerosi N; Amulen PM; Hansen R; Borok MZ; Carrilho C; Mallé B; Ahoui Apendi C; Buziba NG; Seife E; Liu B; Mikolajczyk R; Parkin DM; Kantelhardt EJ; Jemal A
    J Natl Compr Canc Netw; 2023 Sep; 21(9):924-933.e7. PubMed ID: 37673109
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Acceptability of a shared cancer follow-up model of care between general practitioners and radiation oncologists: A qualitative evaluation.
    Sandell T; Schütze H; Miller A
    Health Expect; 2023 Dec; 26(6):2441-2452. PubMed ID: 37583292
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Risk factors analysis and prediction model construction of submucosal deep infiltration of early colorectal tumor].
    Chen ZH; Dou LZ; Zhang YM; Liu Y; He S; Ke Y; Liu XD; Liu YM; Wu HR; Zou SM; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):613-620. PubMed ID: 37462018
    [No Abstract]    [Full Text] [Related]  

  • 7. Rates and Patterns of Recurrence After Microwave Ablation of colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Karagkounis G; McIntyre SM; Wang T; Chou JF; Nasar N; Gonen M; Balachandran VP; Wei AC; Soares KC; Drebin JA; D'Angelica MI; Jarnagin WR; Kingham TP
    Ann Surg Oncol; 2023 Oct; 30(11):6571-6578. PubMed ID: 37365414
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological Characteristics and Outcomes of Anal Squamous Cell Carcinoma Patients With and Without HIV Infection in Sub-Saharan Africa.
    Mduma E; Dharsee N; Samwel K; Mwita CJ; Lidenge SJ
    JCO Glob Oncol; 2023 May; 9():e2200394. PubMed ID: 37216622
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The impact of time to surgery on oncological outcomes in stage I-III dMMR colon cancer - A nationwide cohort study.
    Justesen TF; Gögenur M; Clausen JSR; Mashkoor M; Rosen AW; Gögenur I
    Eur J Surg Oncol; 2023 Sep; 49(9):106887. PubMed ID: 37002178
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Correlation between pelvic relapses of rectal cancer after radical and R0 resection: A regression model-based analysis].
    Guo P; Tao L; Wang C; Lyu HR; Yang Y; Hu H; Li GX; Liu F; Li YX; Ye YJ; Wang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):277-282. PubMed ID: 36925128
    [No Abstract]    [Full Text] [Related]  

  • 11. The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.
    Su YT; Chen JW; Chang SC; Jiang JK; Huang SC
    Sci Rep; 2022 Nov; 12(1):20075. PubMed ID: 36418865
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Current Practice Patterns in Locally Advanced Rectal cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and colorectal Surgeons.
    Wu TC; Sanford NN; Anand S; Chu FI; Wo JY; Raldow AC
    Clin Colorectal Cancer; 2022 Dec; 21(4):309-314. PubMed ID: 36216758
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Access to and Affordability of World Health Organization Essential Medicines for cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
    Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
    Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Liu T; Jiang S; Teng X; Zhong L; Liu M; Jin Y; Dong M
    Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):1-9. PubMed ID: 35950851
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management.
    Murakami T; Kurosawa T; Fukushima H; Shibuya T; Yao T; Nagahara A
    Dig Endosc; 2022 Sep; 34(6):1096-1109. PubMed ID: 35352394
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancer.
    Derksen JWG; Smit KC; May AM; Punt CJA
    Eur J Cancer; 2022 May; 166():73-86. PubMed ID: 35279472
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic colorectal cancer.
    Redman JM; Tsai YT; Weinberg BA; Donahue RN; Gandhy S; Gatti-Mays ME; Abdul Sater H; Bilusic M; Cordes LM; Steinberg SM; Marte JL; Jochems C; Kim SS; Marshall JL; McMahon S; Redmond E; Schlom J; Gulley JL; Strauss J
    Oncologist; 2022 Mar; 27(3):198-209. PubMed ID: 35274710
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study.
    Kawakami T; Masuishi T; Kawamoto Y; Go H; Kato K; Kumanishi R; Sawada K; Yuki S; Yamamoto K; Komatsu Y; Muro K; Fushiki K; Shirasu H; Yamazaki K
    Cancer Med; 2022 Jun; 11(11):2184-2192. PubMed ID: 35182029
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Efficacy and safety of the "watch-and-wait" approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis.
    Zhang X; Ding R; Li J; Wu T; Shen Z; Li S; Zhang Y; Dong C; Shang Z; Zhou H; Li T; Li G; Li Y
    Surg Endosc; 2022 Apr; 36(4):2233-2244. PubMed ID: 34981233
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Parenchyma Sparing ALPPS Ultrasound Guided Partition Through Segment 4 to Maximize Resectability (with video).
    Botea F; Barcu A; Croitoru A; Tomescu D; Lupescu I; Dumitru R; Herlea V; Verdea C; Becker T; Popescu I; Linecker M
    Chirurgia (Bucur); 2022 Feb; 117(1):81-93. PubMed ID: 34915689
    [TBL] [Abstract] [Full Text] [Related]  


    of 9.